glp-1 weight management program eligibility criteria Who Qualifies for Semaglutide Injections for Loss? GLP-1 Weight-Loss Drug Demonstration Begins

Days 1 through 3

Future developments may include: Broader Clinical Trials Researchers are investigating how GLP-1 medications may benefit individuals without diabetes but with high cardiovascular risk, potentially leading to expanded FDA approvals for heart disease prevention

Less saliva = more bacteria More acid = weaker enamel Fewer nutrients = slower healing Less brushing = more plaque Add them together, and you can see why some patients suddenly find themselves with Ozempic teeth. Whats Next The good news

WE UNDERSTAND THAT HAIR CHANGES CAN BE FRUSTRATING

With proper medical supervision, these risks can be significantly reduced